The Journal of Organic Chemistry
Article
7.45−7.40 (m, 3H), 7.32 (d, J = 8.0 Hz, 2H), 6.95 (s, 1H), 3.24 (s,
3H), 2.45 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 159.3, 146.3,
144.7, 134.2, 130.7, 130.0, 128.9, 128.0, 127.3, 126.3, 122.2, 37.7,
21.8; HRMS (ESI): m/z [M + H]+ calcd for C17H17N2O3S+:
329.0954; found: 329.0966.
NMR (400 MHz, CDCl3) δ 6.95 (s, 2H), 6.53 (s, 1H), 3.21 (s, 3H),
2.53 (s, 6H), 2.42 (s, 3H), 2.30 (s, 3H); 13C{1H} NMR (100 MHz,
CDCl3) δ 160.1, 146.1, 143.7, 140.8, 132.2, 131.4, 120.0, 36.5, 22.9,
21.1, 14.3; HRMS (ESI): m/z [M + H]+ calcd for C14H19N2O3S+:
295.1111; found: 295.1106.
N,4-Dimethyl-N-(2-(o-tolyl)oxazol-5-yl)benzenesulfonamide (3i).
Colorless oil (39.0 mg, 57%); Rf 0.35 (hexane/EtOAc 4:1); 1H NMR
(400 MHz, CDCl3) δ 7.80 (d, J = 7.3 Hz, 1H), 7.67 (d, J = 8.3 Hz,
2H), 7.34−7.31 (m, 3H), 7.26−7.22 (m, 2H), 7.01 (s, 1H), 3.24 (s,
3H), 2.53 (s, 3H), 2.44 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ
159.8 (br.), 146.1 (br.), 144.8, 137.6, 134.1, 131.8, 130.5, 130.0,
128.9, 127.9, 126.2, 125.9, 121.3, 37.5, 21.9, 21.7; HRMS (ESI): m/z
[M + H]+ calcd for C18H19N2O3S+: 343.1111; found: 343.1108.
N,4-Dimethyl-N-(2-(m-tolyl)oxazol-5-yl)benzenesulfonamide
(3g). Colorless solid (52.7 mg, 74%); mp 59.0−60.0 °C (hexane/
EtOAc); Rf 0.30 (hexane/EtOAc 4:1); 1H NMR (400 MHz, CDCl3)
δ 7.77−7.66 (m, 4H), 7.36−7.24 (m, 4H), 6.94 (s, 1H), 3.23 (s, 3H),
2.44 (s, 3H), 2.39 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ
159.5, 146.3, 144.7, 138.7, 134.2, 131.6, 129.9, 128.8, 128.0, 127.0,
126.9, 123.4, 121.9, 37.7, 21.7, 21.4; HRMS (ESI): m/z [M + H]+
calcd for C18H19N2O3S+: 343.1111; found: 343.1104.
N-Methyl-N-(2-methyloxazol-5-yl)naphthalene-2-sulfonamide
1
(3r). Brownish oil (48.4 mg, 80%); Rf 0.30 (hexane/EtOAc 1:1); H
NMR (400 MHz, CDCl3) δ 8.35 (s, 1H), 7.97 (d, J = 8.5 Hz, 2H),
7.94 (d, J = 8.2 Hz, 1H), 7.71−7.62 (m, 3H), 6.73 (s, 1H), 3.20 (s,
3H), 2.34 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 159.7, 146.0,
135.3, 134.2, 132.2, 129.6, 129.58, 129.5, 129.4, 128.1, 127.9, 122.8,
121.3, 37.9, 14.5; HRMS (ESI): m/z [M + Na]+ calcd for
C15H14N2NaO3S+: 325.0617; found: 325.0609.
N-Methyl-N-(2-methyloxazol-5-yl)-4-nitrobenzenesulfonamide
(3s). Yellow solid (52.3 mg, 88%); mp 113.0−115.0 °C (hexane/
1
EtOAc); Rf 0.30 (hexane/EtOAc 1:1); H NMR (400 MHz, CDCl3)
δ 8.38 (d, J = 8.8 Hz, 2H), 7.95 (d, J = 8.8 Hz, 2H), 6.78 (s, 1H), 3.21
(s, 3H), 2.36 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 160.1,
150.7, 144.9, 143.1, 129.1, 124.6, 121.9, 38.0, 14.5; HRMS (ESI): m/z
[M + H]+ calcd for C11H12N3O5S+: 298.0492; found: 298.0488.
N-Methyl-N-(2-methyloxazol-5-yl)-2-nitrobenzenesulfonamide
(3t). Yellow solid (42.8 mg, 72%); mp 44.5−46.0 °C (hexane/
N-(2-(3-Chloropropyl)oxazol-5-yl)-N,4-dimethylbenzenesulfona-
1
EtOAc); Rf 0.40 (hexane/EtOAc 1:1); H NMR (400 MHz, CDCl3)
mide (3k). Colorless oil (37.5 mg, 57%); Rf 0.50 (hexane/EtOAc
1
δ 7.91 (d, J = 8.1 Hz, 1H), 7.78−7.75 (m, 1H), 7.70−7.66 (m, 2H),
6.77 (s, 1H), 3.36 (s, 3H), 2.41 (s, 3H); 13C{1H} NMR (100 MHz,
CDCl3) δ 160.5, 148.3, 144.7, 134.7, 131.9, 131.7, 131.2, 124.6, 121.6,
38.5, 14.4.; HRMS (ESI): m/z [M + H]+ calcd for C11H12N3O5S+:
298.0492; found: 298.0481.
1:1); H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.4 Hz, 2H), 7.32
(d, J = 8.0 Hz, 2H), 6.73 (s, 1H), 3.57 (t, J = 6.4 Hz, 2H), 3.14 (s,
3H), 2.83 (t, J = 7.3 Hz, 2H), 2.44 (s, 3H), 2.15 (p, J = 6.8 Hz, 2H);
13C{1H} NMR (100 MHz, CDCl3) δ 161.4, 146.2, 144.7, 134.2,
129.9, 127.9, 121.0, 43.7, 37.6, 29.4, 25.7, 21.7; HRMS (ESI): m/z
[M + H]+ calcd for C14H18ClN2O3S+: 329.0721; found: 329.0718.
N-(2-(2-Methoxyethyl)oxazol-5-yl)-N,4-dimethylbenzenesulfo-
namide (3l). Yellowish oil (30.4 mg, 49%); Rf 0.30 (hexane/EtOAc
N-Butyl-4-methyl-N-(2-methyloxazol-5-yl)benzenesulfonamide
1
(3u). Colorless oil (30.8 mg, 50%); Rf 0.40 (hexane/EtOAc 2:1); H
NMR (400 MHz, CDCl3) δ 7.64 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.0
Hz, 2H), 6.68 (s, 1H), 3.43 (t, J = 7.2 Hz, 2H), 2.44 (s, 3H), 2.37 (s,
3H), 1.49−1.42 (m, 2H), 1.36−1.29 (m, 2H), 0.88 (t, J = 7.3 Hz,
3H); 13C{1H} NMR (100 MHz, CDCl3) δ 160.3, 144.5, 144.3, 135.7,
129.8, 127.8, 123.4, 50.4, 30.5, 21.7, 19.6, 14.6, 13.7; HRMS (ESI):
m/z [M + H]+ calcd for C15H21N2O3S+: 309.1267; found: 309.1273.
N-Ethyl-4-methyl-N-(2-methyloxazol-5-yl)benzenesulfonamide
(3w) and N-Ethyl-2-oxo-N-tosylacetamide (3w′). Brownish oil (49.0
1
1:1); H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.3 Hz, 2H), 7.31
(d, J = 7.6 Hz, 2H), 6.73 (s, 1H), 3.69 (t, J = 6.6 Hz, 2H), 3.34 (s,
3H), 3.13 (s, 3H), 2.92 (t, J = 6.6 Hz, 2H), 2.44 (s, 3H); 13C{1H}
NMR (100 MHz, CDCl3) δ 160.3, 146.2, 144.6, 134.2, 129.9, 128.0,
121.1, 69.1, 58.9, 37.6, 29.3, 21.7; HRMS (ESI): m/z [M + H]+ calcd
for C14H19N2O4S+: 311.1060; found: 311.1067.
N-Methyl-N-(2-methyloxazol-5-yl)benzenesulfonamide (3m).
Colorless oil (38.9 mg, 77%); Rf 0.30 (hexane/EtOAc 1:1); 1H
NMR (400 MHz, CDCl3) δ 7.77−7.75 (m, 2H), 7.64 (t, J = 7.5 Hz,
1H), 7.53 (t, J = 7.7 Hz, 2H), 6.69 (s, 1H), 3.16 (s, 3H), 2.35 (s, 3H);
13C NMR (100 MHz, CDCl3) δ 159.6, 145.9, 137.3, 133.6, 129.3,
1
mg, 58% (3w), 31% (3w′)); Rf 0.60 (hexane/ethyl acetate 1:1); H
NMR for 3w (400 MHz, CDCl3) δ 7.65 (d, J = 8.2 Hz, 2H), 7.31 (d, J
= 8.0 Hz, 2H), 6.74 (s, 1H), 3.52 (q, J = 7.2 Hz, 2H), 2.44 (s, 3H),
1
2.43 (s, 3H), 1.12 (t, J = 7.2 Hz, 3H); H NMR for 3w′ (400 MHz,
127.9, 121.2, 37.8, 14.4; HRMS (ESI): m/z [M + H]+ calcd for
CDCl3) δ 9.66 (s, 1H), 7.79 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.2 Hz,
2H), 3.63 (q, J = 7.1 Hz, 2H), 2.46 (s, 3H), 1.17−1.14 (m, 3H);
13C{1H} NMR for 3w and 3w′ (100 MHz, CDCl3) δ 184.3, 166.1,
C11H13N2O3S+: 253.0641; found: 253.0645.
4-Fluoro-N-methyl-N-(2-methyloxazol-5-yl)benzenesulfonamide
(3n). Colorless solid (36.8 mg, 68%); mp 95.0−97.0 °C (hexane/
EtOAc); Rf 0.35 (hexane/EtOAc 1:1); 1H NMR (400 MHz, CDCl3)
δ 7.74−7.79 (m, 2H), 7.17−7.23 (m, 2H), 6.70 (s, 1H), 3.15 (s, 3H),
2.35 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 165.7 (d, JF =
256.2 Hz), 159.7, 145.7, 133.3 (d, JF = 3.4 Hz), 130.6 (d, JF = 9.4 Hz),
121.4, 116.6 (d, JF = 22.7 Hz), 37.8, 14.4; HRMS (ESI): m/z [M +
H]+ calcd for C11H12FN2O3S+: 271.0547; found: 271.0545.
4-Bromo-N-methyl-N-(2-methyloxazol-5-yl)benzenesulfonamide
(3o). Yellow solid (47.0 mg, 71%); mp 96.0−98.0 °C (hexane/
EtOAc); Rf 0.40 (hexane/EtOAc 1:1); 1H NMR (400 MHz, CDCl3)
δ 7.70−7.66 (m, 2H), 7.63−7.60 (m, 2H), 6.72 (s, 1H), 3.16 (s, 3H),
2.37 (s, 3H); 13C{1H} NMR (100 MHz, CDCl3) δ 159.9, 145.6,
136.2, 132.6, 129.3, 128.9, 121.2, 37.8, 14.4; HRMS (ESI): m/z [M +
Na]+ calcd for C11H11BrN2NaO3S+: 352.9566; found: 352.9561.
4 - M e t h o x y - N - m e t h y l - N - ( 2 - m e t h y l o x a z o l - 5 - y l ) -
benzenesulfonamide (3p). Colorless oil (35.6 mg, 63%, 91% purity
form NMR assay); Rf 0.40 (hexane/EtOAc 1:1); 1H NMR (400
MHz, CDCl3) δ 7.68 (d, J = 8.9 Hz, 2H), 6.98 (d, J = 8.9 Hz, 2H),
6.67 (s, 1H,), 3.88 (s, 3H), 3.13 (s, 3H), 2.36 (s, 3H); 13C{1H} NMR
(100 MHz, CDCl3) δ 163.7, 159.5, 146.3, 130.1, 128.7, 121.0, 114.4,
55.8, 37.7, 14.5; HRMS (ESI): m/z [M + H]+ calcd for
C12H15N2O4S+: 283.0747; found: 283.0753.
160.7, 151.0, 146.2, 144.5, 135.6, 134.4, 130.4, 129.9, 128.2, 127.8,
122.6, 45.8, 40.9, 21.8, 21.7, 14.5, 14.1, 13.6; HRMS (ESI) for 3w: m/
z [M + H]+ calcd for C13H17N2O3S+: 281.0954; found: 281.0944;
HRMS (ESI) for 3w′: m/z [M + Na]+ calcd for C10H11NNaO4S+:
264.0301; found: 264.0305.
N-(2-(Dimethylamino)oxazol-5-yl)-N,4-dimethylbenzenesulfo-
namide (5a). Brown oil (43.7 mg, 74%); Rf 0.30 (hexane/EtOAc
1
1:1); H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.3 Hz, 2H), 7.31
(d, J = 8.1 Hz, 2H), 6.46 (s, 1H), 3.11 (s, 3H), 2.95 (s, 6H), 2.44 (s,
3H); 13C{1H} NMR (100 MHz, CDCl3) δ 160.1, 144.2, 139.9, 134.7,
129.7, 128.1, 123.1, 38.6, 37.4, 21.7; HRMS (ESI): m/z [M + H]+
calcd for C13H18N3O3S+: 296.1063; found: 296.1071.
N-(2-(Diethylamino)oxazol-5-yl)-N,4-dimethylbenzenesulfona-
mide (5b). Browm oil (50.5 mg, 78%); Rf 0.50 (hexane/EtOAc 1:1);
1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.2 Hz, 2H), 7.30 (d, J =
8.1 Hz, 2H), 6.49 (s, 1H), 3.34 (q, J = 7.1 Hz, 4H), 3.13 (s, 3H), 2.43
(s, 3H), 1.13 (t, J = 7.1 Hz, 6H); 13C{1H} NMR (100 MHz, CDCl3)
δ 159.1, 144.1, 139.3, 134.9, 129.7, 128.0, 123.0, 42.5, 38.5, 21.7, 13.4;
HRMS (ESI): m/z [M + H]+ calcd for C15H22N3O3S+: 324.1376;
found: 324.1387.
N, 4-Dimethyl-N-(2-(pyrrolidin-1-yl)oxazol-5-yl)-
benzenesulfonamide (5c). Yellowish oil (42.4 mg, 66%); Rf 0.50
(hexane/EtOAc 1:1); 1H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 8.3
Hz, 2H), 7.30 (d, J = 7.6 Hz, 2H), 6.45 (s, 1H), 3.40−3.37 (m, 4H),
3.10 (s, 3H), 2.43 (s, 3H), 1.97−1.91 (m, 4H); 13C{1H} NMR (100
N , 2 , 4 , 6 - T e t r a m e t h y l - N - ( 2 - m e t h y l o x a z o l - 5 - y l ) -
benzenesulfonamide (3q). Colorless solid (38.9 mg, 66%); mp
85.0−87.0 °C (hexane/EtOAc); Rf 0.30 (hexane/EtOAc 2:1); 1H
1752
J. Org. Chem. 2021, 86, 1748−1757